What are the recommended treatments for headaches?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Headaches

For acute migraine, start with ibuprofen 400-800 mg or naproxen 500-825 mg as first-line therapy for mild-to-moderate attacks, escalating to a triptan (sumatriptan 50-100 mg) combined with an NSAID for moderate-to-severe attacks or when NSAIDs alone fail. 1, 2

Migraine Treatment Algorithm

First-Line Acute Treatment (Mild-to-Moderate Migraine)

  • NSAIDs are the initial choice: Ibuprofen 400-800 mg, naproxen sodium 500-825 mg, or aspirin 650-1000 mg taken at headache onset 1, 2, 3
  • Acetaminophen 1000 mg is an alternative when NSAIDs are contraindicated, though less effective (NNT 12 for 2-hour pain-free response versus NNT 7.2 for ibuprofen 400 mg) 1, 4, 5
  • Combination therapy with aspirin + acetaminophen + caffeine provides synergistic benefit for patients responding poorly to single-agent NSAIDs 1, 2

Second-Line Acute Treatment (Moderate-to-Severe Migraine)

  • Triptans are the cornerstone: Sumatriptan 50-100 mg, rizatriptan, naratriptan, or zolmitriptan taken early in the attack 1, 2, 6
  • Combination therapy is superior to monotherapy: Triptan + NSAID (e.g., sumatriptan 100 mg + naproxen 500 mg) provides the highest efficacy, with 130 additional patients per 1000 achieving sustained pain relief at 48 hours compared to either agent alone 2
  • Subcutaneous sumatriptan 6 mg delivers the fastest and most effective relief (59% pain-free at 2 hours, onset within 15 minutes) for severe attacks or when vomiting prevents oral intake 1, 2, 6

Third-Line Acute Treatment (Refractory Cases)

  • CGRP antagonists (gepants): Rimegepant or ubrogepant when triptans fail or are contraindicated 1, 2, 7
  • Dihydroergotamine (DHE): Intranasal or IV formulation for triptan-refractory migraine 1, 2, 7
  • Greater occipital nerve block: For short-term treatment when pharmacotherapy fails 1

Adjunctive Therapy for Nausea/Vomiting

  • Metoclopramide 10 mg IV or oral provides direct analgesic effects beyond antiemetic properties through central dopamine receptor antagonism 2, 7
  • Prochlorperazine 10 mg IV is equally effective to metoclopramide with a more favorable side effect profile (21% adverse events versus 50% with chlorpromazine) 2
  • Add antiemetics 20-30 minutes before analgesics to enhance absorption and provide synergistic pain relief 2

Emergency Department "Migraine Cocktail"

  • Optimal IV combination: Metoclopramide 10 mg IV + ketorolac 30 mg IV provides rapid relief with minimal rebound risk 2, 7
  • Alternative: Prochlorperazine 10 mg IV + ketorolac 30 mg IV for patients intolerant to metoclopramide 2
  • Avoid IV ketamine for acute migraine treatment 1

Tension-Type Headache Treatment

Acute Treatment

  • Ibuprofen 400 mg or acetaminophen 1000 mg as first-line therapy 1, 8

Preventive Treatment (Chronic Tension-Type Headache)

  • Amitriptyline 30-150 mg daily is the recommended preventive agent 1, 8
  • Avoid botulinum toxin injections for chronic tension-type headache prevention 1

Cluster Headache Treatment

Acute Treatment

  • Subcutaneous sumatriptan 6 mg or intranasal zolmitriptan 10 mg are first-line abortive agents 1, 8
  • Normobaric oxygen therapy (high-flow oxygen via non-rebreather mask) provides effective relief 1
  • Noninvasive vagus nerve stimulation for episodic cluster headache 1

Preventive Treatment

  • Galcanezumab for episodic cluster headache prevention 1, 8
  • Avoid galcanezumab for chronic cluster headache (insufficient efficacy) 1
  • Insufficient evidence for verapamil despite widespread clinical use 1

Critical Medication Frequency Limitation

Restrict all acute headache medications to no more than 2 days per week (or 8-10 days per month) to prevent medication-overuse headache, which paradoxically increases headache frequency and can lead to daily headaches. 1, 2, 7

  • When patients require acute treatment more than twice weekly, immediately initiate preventive therapy rather than increasing acute medication frequency 2
  • Medication-overuse headache develops with ≥15 days/month of NSAID use or ≥10 days/month of triptan use 7

Treatments to Avoid

  • Opioids (hydromorphone, meperidine, oxycodone) should be avoided due to dependency risk, rebound headaches, and loss of efficacy; reserve only for cases where all other options are contraindicated and abuse risk has been addressed 1, 2, 7
  • Butalbital-containing compounds carry similar risks of dependency and medication-overuse headache 2, 7
  • IV ketamine is not recommended for acute migraine treatment 1
  • Implantable sphenopalatine ganglion stimulators are not recommended for cluster headache 1
  • Patent foramen ovale closure is not recommended for migraine treatment or prevention 1

Nonpharmacologic Adjuncts

  • Physical therapy for tension-type, migraine, or cervicogenic headache management 1
  • Aerobic exercise or progressive strength training for prevention of tension-type and migraine headaches 1
  • Insufficient evidence currently exists to recommend for or against acupuncture, biofeedback, cognitive behavioral therapy, or mindfulness-based therapies, though these may be considered as adjuncts 1

Common Pitfalls to Avoid

  • Do not delay triptan administration: Triptans work best when taken early during the attack while pain is still mild, not after waiting to see if NSAIDs work 2
  • Do not assume all triptans are equivalent: Failure of one triptan does not predict failure of others; trial a different triptan before abandoning the class 2
  • Do not use antiemetics only for vomiting patients: Nausea itself is disabling and warrants treatment even without vomiting 2
  • Do not continue ineffective acute therapy: If a patient requires acute treatment more than twice weekly, transition to preventive therapy immediately rather than allowing escalating acute medication use 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Ibuprofen with or without an antiemetic for acute migraine headaches in adults.

The Cochrane database of systematic reviews, 2013

Guideline

Acute Migraine Treatment in the Emergency Department

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tratamiento de la Cefalea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.